Back
Maze Therapeutics, Inc. MAZE · Insights
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precisi... Price34.91
Market Cap1.94 B
Float16.04 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro